Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Effects of Treatments on Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by NIAMS is evaluating treatments for atopic dermatitis (eczema) and related dermatitis conditions, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Eczema, Dermatitis | Phase 2 | Status: RECRUITING